Global Personalized Cell Therapeutic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Personalized Cell Therapeutic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Personalized cells are undifferentiated stem cells that can be divided to generate offspring cells designated as specialized or personalized stem cells. Specialized treatment of numerous chronic diseases such as autoimmune and cancer through vaccinating living cells into the body of patients to boost the personalized cell therapy market. As there are multiple types of living cells such as immature and mature living cell, blood and bone marrow cell and embryonic stem cells that are mainly utilized in personalized cell therapy.
Personalized Cell Therapeutic report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Personalized Cell Therapeutic market is projected to reach US$ 26100 million in 2033, increasing from US$ 12570 million in 2022, with the CAGR of 11.0% during the period of 2023 to 2033. Demand from Cardiovascular Diseases and Neurological Disorders are the major drivers for the industry.
Several manufacturers are conducting numerous clinical trials to develop new personalized cell therapies for chronic diseases such as cancer, diabetes and other autoimmune diseases. For example, in April 2019, Orgenesis Inc. received approval from the Institutional Review Board (IRB) to collect liver biopsy samples from patients at the Rambam Medical Center in Israel. Samples were collected to confirm the safety and efficacy of hepatocytes for individualized cell replacement therapy in patients with insulin-dependent diabetes mellitus following total or partial pancreatectomy. Hence, increasing number of studies is expected to boost the growth of the global personalized cell therapy market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Personalized Cell Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
AstraZeneca
GSK Plc
Pfizer Inc
Amneal Pharmaceuticals LLC
Alvogen
F. Hoffmann-La Roche Ltd
Amgen Inc
Jazz Pharmaceuticals, Inc
Amicus Therapeutics, Inc
MeiraGTx Limited
Rocket Pharmaceuticals, Inc
Gilead Sciences, Inc
Segment by Type
Embryonic Stem Cells
Adult Stem Cell
Induced Pluripotent Cells
Other
Cardiovascular Diseases
Neurological Disorders
Diabetes
Oncology
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Personalized Cell Therapeutic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Personalized Cell Therapeutic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Personalized Cell Therapeutic industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Personalized Cell Therapeutic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Personalized Cell Therapeutic introduction, etc. Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Personalized Cell Therapeutic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Personalized Cell Therapeutic report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Personalized Cell Therapeutic market is projected to reach US$ 26100 million in 2033, increasing from US$ 12570 million in 2022, with the CAGR of 11.0% during the period of 2023 to 2033. Demand from Cardiovascular Diseases and Neurological Disorders are the major drivers for the industry.
Several manufacturers are conducting numerous clinical trials to develop new personalized cell therapies for chronic diseases such as cancer, diabetes and other autoimmune diseases. For example, in April 2019, Orgenesis Inc. received approval from the Institutional Review Board (IRB) to collect liver biopsy samples from patients at the Rambam Medical Center in Israel. Samples were collected to confirm the safety and efficacy of hepatocytes for individualized cell replacement therapy in patients with insulin-dependent diabetes mellitus following total or partial pancreatectomy. Hence, increasing number of studies is expected to boost the growth of the global personalized cell therapy market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Personalized Cell Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
AstraZeneca
GSK Plc
Pfizer Inc
Amneal Pharmaceuticals LLC
Alvogen
F. Hoffmann-La Roche Ltd
Amgen Inc
Jazz Pharmaceuticals, Inc
Amicus Therapeutics, Inc
MeiraGTx Limited
Rocket Pharmaceuticals, Inc
Gilead Sciences, Inc
Segment by Type
Embryonic Stem Cells
Adult Stem Cell
Induced Pluripotent Cells
Other
Segment by Application
Cardiovascular Diseases
Neurological Disorders
Diabetes
Oncology
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Personalized Cell Therapeutic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Personalized Cell Therapeutic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Personalized Cell Therapeutic industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Personalized Cell Therapeutic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Personalized Cell Therapeutic introduction, etc. Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Personalized Cell Therapeutic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.